Search results
Results from the WOW.Com Content Network
The Edinburgh Cancer Research Centre was established in The University of Edinburgh (UoE) in close partnership with Cancer Research UK and the NHS Lothian, and has strong links to other Institutes and Colleges conducting cancer research in Edinburgh, in particular the Institute of Genetics & Molecular Medicine. The ECRC follows a partnership ...
Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. [ 2 ] [ 3 ] It is registered as a charity in the United Kingdom [ 1 ] and Isle of Man , and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund . [ 4 ]
Genomics England was formally established as a company on 17 April 2013 [8] and was formally launched on 5 July 2013 as part of the celebrations for the 65th Birthday of the UK's National Health Service [9] In August 2014, the Wellcome Trust announced that it was investing £27 million in a genome-sequencing hub for Genomics England, allowing the company to become part of the Wellcome Trust ...
In 2007 the Human Genetics Unit formed a partnership with two neighbouring research centres on the Western General Hospital campus, the Centre for Genomic and Experimental Medicine (University of Edinburgh) and the Edinburgh Cancer Research Centre (Cancer Research UK), to create the Institute of Genetics and Molecular Medicine.
Scientific research at the Sanger Institute is organised into five Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. The current Programmes at the Sanger Institute are Cancer, Ageing and Somatic Mutation, Cellular Genetics, Human Genetics, Parasites and Microbes and Tree of Life.
In follow-up research at the ICR in 1964, Professors Peter Brookes and Philip Lawley proved that chemical carcinogens act by damaging DNA, leading to mutations and the formation of tumours, proving that cancer is a genetic disease based on mutational events. [7] In 1954 the institute was officially renamed The Institute of Cancer Research (ICR).
A 2019 review identified the initiative as an 'exemplar' in involving the public in genomic research. [16] In June 2020, Lifebit, a UK-based biotechnology company, was announced as the provider of the trusted research environment that will link the genomic data gathered as part of the 100,000 Genome Project with academic research institutions.
The Institute was founded in 1989 to provide a rich, collaborative environment for scientists working in diverse but complementary specialities in the fields of developmental biology and cancer biology. It receives its primary funding from the Wellcome Trust and Cancer Research UK. [6]